GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is Glp 3 rt now emerging as a prominent focus in healthcare studies, largely due to its notable impact on treating ailments such as adult-onset diabetes and obesity. Recent research have revealed that more than glucose control, GLP-1 agonists offer potential for cardiovascular well-being a